NASDAQ · APGN
Healthcare · Biotechnology
$0.39
Up+$0.03 (+8.48%)
Updated Aug 23, 2026, 5:52 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
APGN does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning APGN.
APGN research
Company profile and research snapshot.
Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells. The company was founded in 2010 and is based in San Carlos, California.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 26, 2023 | EF Hutton | Hold | — |
| May 24, 2023 | EF Hutton | Hold | — |
| May 16, 2023 | EF Hutton | Buy | — |
| Jan 24, 2023 | Roth Capital | Buy | — |
| Jan 5, 2023 | EF Hutton | Buy | — |
No generated briefing is available yet.
GlobeNewswire Inc. · Jun 3, 2023
- Marked increases in overall survival observed across soft tissue sarcoma patients -
Zacks Investment Research · Mar 20, 2023
Here is how Apexigen, Inc. (APGN) and ASLAN Pharmaceuticals Ltd. (ASLN) have performed compared to their sector so far this year.
PennyStocks · Jan 25, 2023
Analysts have put these on their list of penny stocks to buy. Do you agree? The post 4 Penny Stocks To Buy According To Analysts & Targets Over 600% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks · Jan 19, 2023
Penny stocks to buy according to analysts. The post 4 Penny Stocks To Buy According To Insiders & Targets Up To 347% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning APGN.
No results
No recent SID articles mention APGN.
